October 14, 2016
Aeterna Zentaris licenses its anti-cancer Zoptrex in Australia and New Zealand
Canadian biopharmaceutical company Aeterna Zentaris, Inc., has signed an additional licensing agreement with Specialised Therapeutics Asia (“STA”) for its anti-cancer compound, Zoptrex.